Vectus Biosystems Ltd (VBS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 2.572x

Based on the latest financial reports, Vectus Biosystems Ltd (VBS) has a cash flow conversion efficiency ratio of 2.572x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-659.98K ≈ $-466.98K USD) by net assets (AU$-256.62K ≈ $-181.58K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VBS equity financing ratio to measure how much of total assets are equity-financed.

Vectus Biosystems Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Vectus Biosystems Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Vectus Biosystems Ltd (VBS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Vectus Biosystems Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vectus Biosystems Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tarena International Inc NASDAQ:TCTM	N/A
Lycaon Resources Ltd AU:LYN	-0.022x
Akbar Indomakmur Stimec Tbk JK:AIMS	1.357x
Granada Gold Mine Inc V:GGM	0.002x
Permaju Industries Bhd KLSE:7080	0.010x
Porvair plc LSE:PRV	0.095x
TENET FINTECH GROUP INC. F:P0T	-17.433x
WFM Inc. KQ:035290	0.014x

Annual Cash Flow Conversion Efficiency for Vectus Biosystems Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Vectus Biosystems Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Vectus Biosystems Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-256.62K ≈ $-181.58K	AU$-830.09K ≈ $-587.34K	3.235x	+336.52%
2024-06-30	AU$1.49 Million ≈ $1.05 Million	AU$-2.03 Million ≈ $-1.44 Million	-1.368x	-104.82%
2023-06-30	AU$3.52 Million ≈ $2.49 Million	AU$-2.35 Million ≈ $-1.66 Million	-0.668x	-166.48%
2022-06-30	AU$-4.42 Million ≈ $-3.13 Million	AU$-4.44 Million ≈ $-3.14 Million	1.004x	-10.54%
2021-06-30	AU$-2.90 Million ≈ $-2.05 Million	AU$-3.26 Million ≈ $-2.30 Million	1.123x	+151.03%
2020-06-30	AU$-6.71 Million ≈ $-4.75 Million	AU$-3.00 Million ≈ $-2.12 Million	0.447x	+60.32%
2019-06-30	AU$-3.73 Million ≈ $-2.64 Million	AU$-1.04 Million ≈ $-736.30K	0.279x	-54.62%
2018-06-30	AU$-2.26 Million ≈ $-1.60 Million	AU$-1.39 Million ≈ $-981.46K	0.615x	+101.84%
2017-06-30	AU$116.56K ≈ $82.48K	AU$-3.89 Million ≈ $-2.75 Million	-33.399x	-4696.01%
2016-06-30	AU$3.75 Million ≈ $2.65 Million	AU$-2.61 Million ≈ $-1.85 Million	-0.696x	-376.09%
2015-06-30	AU$11.22 Million ≈ $7.94 Million	AU$-1.64 Million ≈ $-1.16 Million	-0.146x	+99.37%
2014-06-30	AU$55.53K ≈ $39.29K	AU$-1.29 Million ≈ $-915.18K	-23.292x	-1926.15%
2013-06-30	AU$976.04K ≈ $690.61K	AU$-1.12 Million ≈ $-793.92K	-1.150x	-141.21%
2012-06-30	AU$-504.57K ≈ $-357.02K	AU$-1.41 Million ≈ $-995.86K	2.789x	--

About Vectus Biosystems Ltd

AU:VBS Australia Biotechnology

Market Cap

$4.91 Million

AU$6.95 Million AUD

Market Cap Rank

#28588 Global

#1522 in Australia

Share Price

AU$0.13

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.44

All Time High

AU$2.00